# Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

> **NCT03300518** · NA · COMPLETED · sponsor: **Reproductive & Genetic Hospital of CITIC-Xiangya** · enrollment: 552 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Follitropin Beta;MSD
- **DRUG:** Ganirelix
- **DRUG:** hCG
- **DRUG:** estradiol valerate

## Key facts

- **NCT ID:** NCT03300518
- **Lead sponsor:** Reproductive & Genetic Hospital of CITIC-Xiangya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2021-06-18
- **Final completion:** 2021-08-18
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2022-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03300518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03300518, "Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03300518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*